» Articles » PMID: 21558814

Evidence for a Stromal-epithelial "lactate Shuttle" in Human Tumors: MCT4 is a Marker of Oxidative Stress in Cancer-associated Fibroblasts

Abstract

Recently, we proposed a new mechanism for understanding the Warburg effect in cancer metabolism. In this new paradigm, cancer-associated fibroblasts undergo aerobic glycolysis, and extrude lactate to "feed" adjacent cancer cells, which then drives mitochondrial biogenesis and oxidative mitochondrial metabolism in cancer cells. Thus, there is vectorial transport of energy-rich substrates from the fibroblastic tumor stroma to anabolic cancer cells. A prediction of this hypothesis is that cancer-associated fibroblasts should express MCT4, a mono-carboxylate transporter that has been implicated in lactate efflux from glycolytic muscle fibers and astrocytes in the brain. To address this issue, we co-cultured MCF7 breast cancer cells with normal fibroblasts. Interestingly, our results directly show that breast cancer cells specifically induce the expression of MCT4 in cancer-associated fibroblasts; MCF7 cells alone and fibroblasts alone, both failed to express MCT4. We also show that the expression of MCT4 in cancer-associated fibroblasts is due to oxidative stress, and can be prevented by pre-treatment with the anti-oxidant N-acetyl-cysteine. In contrast to our results with MCT4, we see that MCT1, a transporter involved in lactate uptake, is specifically upregulated in MCF7 breast cancer cells when co-cultured with fibroblasts. Virtually identical results were also obtained with primary human breast cancer samples. In human breast cancers, MCT4 selectively labels the tumor stroma, e.g., the cancer-associated fibroblast compartment. Conversely, MCT1 was selectively expressed in the epithelial cancer cells within the same tumors. Functionally, we show that overexpression of MCT4 in fibroblasts protects both MCF7 cancer cells and fibroblasts against cell death, under co-culture conditions. Thus, we provide the first evidence for the existence of a stromal-epithelial lactate shuttle in human tumors, analogous to the lactate shuttles that are essential for the normal physiological function of muscle tissue and brain. These data are consistent with the "reverse Warburg effect," which states that cancer-associated fibroblasts undergo aerobic glycolysis, thereby producing lactate, which is utilized as a metabolic substrate by adjacent cancer cells. In this model, "energy transfer" or "metabolic-coupling" between the tumor stroma and epithelial cancer cells "fuels" tumor growth and metastasis, via oxidative mitochondrial metabolism in anabolic cancer cells. Most importantly, our current findings provide a new rationale and novel strategy for anti-cancer therapies, by employing MCT inhibitors.

Citing Articles

Metabolic adaptation of myeloid cells in the glioblastoma microenvironment.

Essakhi N, Bertucci A, Baeza-Kallee N, Colin C, Lavignolle-Heguy R, Garcia-Gonzalez P Front Immunol. 2025; 15:1431112.

PMID: 39763643 PMC: 11700814. DOI: 10.3389/fimmu.2024.1431112.


Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironment.

Han X, Burrows M, Kim L, Xu J, Vostrejs W, Van Le T Cell Rep. 2024; 43(11):114972.

PMID: 39535921 PMC: 11648993. DOI: 10.1016/j.celrep.2024.114972.


Monocarboxylate transporter dependent mechanism is involved in proliferation, migration, and invasion of human glioblastoma cell lines via activation of PI3K/Akt signaling pathway.

Gao C, Yang B, Li Y, Pei W PLoS One. 2024; 19(10):e0312939.

PMID: 39475905 PMC: 11524508. DOI: 10.1371/journal.pone.0312939.


Envisioning Glucose Transporters (GLUTs and SGLTs) as Novel Intervention against Cancer: Drug Discovery Perspective and Targeting Approach.

Shafi S, Ahmed Khan M, Ahmad J, Rabbani S, Singh S, Najmi A Curr Drug Targets. 2024; 26(2):109-131.

PMID: 39377414 DOI: 10.2174/0113894501335877240926101134.


Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts.

Koltai T, Fliegel L Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931411 PMC: 11206832. DOI: 10.3390/ph17060744.


References
1.
McConnell A, Parfitt V, Walker P . An unusual case of shock in a young woman. Postgrad Med J. 1989; 65(760):120. PMC: 2429109. DOI: 10.1136/pgmj.65.760.120. View

2.
Pierre K, Pellerin L . Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem. 2005; 94(1):1-14. DOI: 10.1111/j.1471-4159.2005.03168.x. View

3.
Evans T, Stein R, Ford H, Gazet J, Chamberlain G, Coombes R . Lactic acidosis. A presentation of metastatic breast cancer arising in pregnancy. Cancer. 1992; 69(2):453-6. DOI: 10.1002/1097-0142(19920115)69:2<453::aid-cncr2820690230>3.0.co;2-n. View

4.
Martinez-Outschoorn U, Prisco M, Ertel A, Tsirigos A, Lin Z, Pavlides S . Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle. 2011; 10(8):1271-86. PMC: 3117136. DOI: 10.4161/cc.10.8.15330. View

5.
Sloan E, Ciocca D, Pouliot N, Natoli A, Restall C, Henderson M . Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol. 2009; 174(6):2035-43. PMC: 2684169. DOI: 10.2353/ajpath.2009.080924. View